Shopping Cart 0
Cart Subtotal
USD 0

Global Genomics Market (By Products & Services - Instruments/Systems, Consumables and Services, By Technology- PCR (Polymerase Chain Reaction), DNA Microarray, Sequencing, Nucleic Acid Extraction & Purification and Others, By Application - Diagnostics, Personalized Medicine, Drug Discovery & Development, Agriculture & Animal Research and Others, By Process- Library Preparation, Gene Sequencing and data analysis, By End-User- Hospital & Clinics, Research enters, Government & academic Institutes, Pharmaceutical & Biotechnology Companies and Others); - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4795

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6795

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7795
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

The report covers the analysis and forecast of the global genomics market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Bn).

The study provides a detailed view of the global genomics market, by segmenting it based on, product and services, technology, application, process, end-user and regional demand. The products and services type segment include instruments/systems, consumables and services, while based on technology, it includes PCR (polymerase chain reaction), DNA microarray, DNA sequencing, nucleic acid extraction and purification and others (genotyping and gene editing). On the other hand, application wise, the segments are diagnostics, personalized medicine, drug discovery and development, agriculture and animal research and others and by process the market is classified into library preparation, gene sequencing and data analysis. By end-user, the genomics market can be segmented into hospital and clinics, research centers, government and academic institutes, pharmaceutical and biotechnology companies and others (NGO's and agri-genomics organizations).

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Market dynamics for each region has been provided in the report.

READ MORE

Table Of Content

Scope

1 INTRODUCTION

1.1 MARKET SEGMENTATION

2 RESEARCH METHODOLOGY

2.1 ECOSYSTEM OF GLOBAL GENOMICS MARKET

2.2 TOP-DOWN APPROACH

2.3 BOTTOM-UP APPROACH

2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 GLOBAL GENOMICS MARKET SNAPSHOT

3.2 GLOBAL GENOMICS MARKET REVENUE, 2017-2025 (USD BN)

4 MARKET OVERVIEW

4.1 INTRODUCTION

4.2 KEY TRENDS ANALYSIS

4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS

4.4 PORTERS FIVE FORCE ANALYSIS

4.5 VALUE CHAIN ANALYSIS

4.6 COMPETITIVE LANDSCAPE

4.7 COMPANY MARKET SHARE ANALYSIS, %, 2017

4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS

5 GLOBAL GENOMICS MARKET, BY PRODUCTS AND SERVICES

5.1 OVERVIEW

5.2 GLOBAL GENOMICS MARKET FOR INSTRUMENTS/SYSTEMS, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

5.3 GLOBAL GENOMICS MARKET FOR, CONSUMABLES, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

5.4 GLOBAL GENOMICS MARKET FOR SERVICES, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

6 GLOBAL GENOMICS MARKET, BY TECHNOLOGY

6.1 OVERVIEW

6.2 GLOBAL GENOMICS MARKET FOR PCR (POLYMERASE CHAIN REACTION), VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

6.3 GLOBAL GENOMICS MARKET FOR DNA MICROARRAY, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

6.4 GLOBAL GENOMICS MARKET FOR DNA SEQUENCING, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

6.5 GLOBAL GENOMICS MARKET FOR, NUCLEIC ACID EXTRACTION AND PURIFICATION, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

6.6 GLOBAL GENOMICS MARKET FOR OTHERS (GENOTYPING AND GENE EDITING), VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

7 GLOBAL GENOMICS MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 GLOBAL GENOMICS MARKET FOR, DIAGNOSTICS, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

7.3 GLOBAL GENOMICS MARKET FOR PERSONALIZED MEDICINE, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

7.4 GLOBAL GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

7.5 GLOBAL GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

7.6 GLOBAL GENOMICS MARKET FOR OTHERS (COALMINES,BIOFUELS AND MARINE RESEARCH) VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

8 GLOBAL GENOMICS MARKET, BY PROCESS

8.1 OVERVIEW

8.2 GLOBAL GENOMICS MARKET FOR LIBRARY PREPARATION, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

8.3 GLOBAL GENOMICS MARKET FOR GENE SEQUENCING, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

8.4 GLOBAL GENOMICS MARKET FOR DATA ANALYSIS, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

9 GLOBAL GENOMICS MARKET, BY END-USER

9.1 OVERVIEW

9.2 GLOBAL GENOMICS MARKET FOR, HOSPITALS AND CLINICS, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

9.3 GLOBAL GENOMICS MARKET FOR RESEARCH CENTERS, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

9.4 GLOBAL GENOMICS MARKET FOR GOVERNMENT AND ACADEMIC INSTITUTES, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

9.5 GLOBAL GENOMICS MARKET FOR PHARMACEUTICALS AND BIOTECHNOLOGICAL COMPANIES, VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

9.6 GLOBAL GENOMICS MARKET FOR OTHERS (SUCH AS NGO'S AND AGRI-GENOMICS ORGANIZATIONS) VOLUME AND REVENUE, 2017-2025, (UNITS) (USD BN)

10 GLOBAL GENOMICS MARKET, BY GEOGRAPHY

10.1 NORTH AMERICA

10.1.1 MARKET DYNAMICS

10.1.1.1 Drivers

10.1.1.2 Restraints

10.1.1.3 Opportunity

10.1.2 U.S.

10.1.3 CANADA

10.1.4 MEXICO

10.2 EUROPE

10.2.1 MARKET DYNAMICS

10.2.1.1 Drivers

10.2.1.2 Restraints

10.2.1.3 Opportunity

10.2.2 U.K.

10.2.3 ITALY

10.2.4 FRANCE

10.2.5 GERMANY

10.2.6 RUSSIA

10.2.7 SPAIN

10.2.8 REST OF EUROPE

10.3 ASIA PACIFIC

10.3.1 MARKET DYNAMICS

10.3.1.1 Drivers

10.3.1.2 Restraints

10.3.1.3 Opportunity

10.3.2 INDIA

10.3.3 CHINA

10.3.4 JAPAN

10.3.5 AUSTRALIA

10.3.6 REST OF ASIA PACIFIC

10.4 MIDDLE EAST AND AFRICA

10.4.1 MARKET DYNAMICS

10.4.1.1 Drivers

10.4.1.2 Restraints

10.4.1.3 Opportunity

10.4.2 GCC

10.4.3 SOUTH AFRICA

10.4.4 REST OF MIDDLE EAST AND AFRICA

10.5 LATIN AMERICA

10.5.1 MARKET DYNAMICS

10.5.1.1 Drivers

10.5.1.2 Restraints

10.5.1.3 Opportunity

10.5.2 BRAZIL

10.5.3 REST OF LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 NEW PRODUCT LAUNCHES

12 GLOBAL GENOMICS MARKET, BY COMPANY

12.1 INTRODUCTION

12.2 AGILENT TECHNOLOGIES

12.2.1 BUSINESS OVERVIEW

12.2.2 PRODUCTS AND SERVICES

12.2.3 KEY STRATEGY

12.2.4 RECENT DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 OUR COMPANY VIEW

12.3 AFFYMETRIX, INC.

12.3.1 BUSINESS OVERVIEW

12.3.2 PRODUCTS AND SERVICES

12.3.3 KEY STRATEGY

12.3.4 RECENT DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 OUR COMPANY VIEW

12.4 BEIJING GENOMICS INSTITUTE (BGI)

12.4.1 BUSINESS OVERVIEW

12.4.2 PRODUCTS AND SERVICES

12.4.3 KEY STRATEGY

12.4.4 RECENT DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 OUR COMPANY VIEW

12.5 DANAHER

12.5.1 BUSINESS OVERVIEW

12.5.2 PRODUCTS AND SERVICES

12.5.3 KEY STRATEGY

12.5.4 RECENT DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 OUR COMPANY VIEW

12.6 EUROFINS SCIENTIFIC

12.6.1 BUSINESS OVERVIEW

12.6.2 PRODUCTS AND SERVICES

12.6.3 KEY STRATEGY

12.6.4 RECENT DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 OUR COMPANY VIEW

12.7 EPPENDORF

12.7.1 BUSINESS OVERVIEW

12.7.2 PRODUCTS AND SERVICES

12.7.3 KEY STRATEGY

12.7.4 RECENT DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 OUR COMPANY VIEW

12.8 F. HOFFMANN-LA ROCHE

12.8.1 BUSINESS OVERVIEW

12.8.2 PRODUCTS AND SERVICES

12.8.3 KEY STRATEGY

12.8.4 RECENT DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 OUR COMPANY VIEW

12.9 GE HEALTHCARE

12.9.1 BUSINESS OVERVIEW

12.9.2 PRODUCTS AND SERVICES

12.9.3 KEY STRATEGY

12.9.4 RECENT DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 OUR COMPANY VIEW

12.10 ILLUMINA INC.

12.10.1 BUSINESS OVERVIEW

12.10.2 PRODUCTS AND SERVICES

12.10.3 KEY STRATEGY

12.10.4 RECENT DEVELOPMENTS

12.10.5 SWOT ANALYSIS

12.10.6 OUR COMPANY VIEW

12.11 LIFE TECHNOLOGIES, INC.

12.11.1 BUSINESS OVERVIEW

12.11.2 PRODUCTS AND SERVICES

12.11.3 KEY STRATEGY

12.11.4 RECENT DEVELOPMENTS

12.11.5 SWOT ANALYSIS

12.11.6 OUR COMPANY VIEW

12.12 OXFORD NANOPORE TECHNOLOGIES

12.12.1 BUSINESS OVERVIEW

12.12.2 PRODUCTS AND SERVICES

12.12.3 KEY STRATEGY

12.12.4 RECENT DEVELOPMENTS

12.12.5 SWOT ANALYSIS

12.12.6 OUR COMPANY VIEW

12.13 PACIFIC BIOSCIENCES OF CALIFORNIA

12.13.1 BUSINESS OVERVIEW

12.13.2 PRODUCTS AND SERVICES

12.13.3 KEY STRATEGY

12.13.4 RECENT DEVELOPMENTS

12.13.5 SWOT ANALYSIS

12.13.6 OUR COMPANY VIEW

12.14 QIAGEN

12.14.1 BUSINESS OVERVIEW

12.14.2 PRODUCTS AND SERVICES

12.14.3 KEY STRATEGY

12.14.4 RECENT DEVELOPMENTS

12.14.5 SWOT ANALYSIS

12.14.6 OUR COMPANY VIEW

12.15 ROCHE DIAGNOSTICS

12.15.1 BUSINESS OVERVIEW

12.15.2 PRODUCTS AND SERVICES

12.15.3 KEY STRATEGY

12.15.4 RECENT DEVELOPMENTS

12.15.5 SWOT ANALYSIS

12.15.6 OUR COMPANY VIEW

12.16 THERMO FISHER SCIENTIFIC

12.16.1 BUSINESS OVERVIEW

12.16.2 PRODUCTS AND SERVICES

12.16.3 KEY STRATEGY

12.16.4 RECENT DEVELOPMENTS

12.16.5 SWOT ANALYSIS

12.16.6 OUR COMPANY VIEW

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com